Physicians' Academy for Cardiovascular Education

Efficacy and Safety of Alirocumab in Patients with Hypercholesterolemia not on Statin Therapy: the ODYSSEY CHOICE II Study

June 19, 2015

Presentation prepared and held by Prof. Erik Stroes (AMC Amsterdam, The Netherlands) in Clinical Breakthroughs session: Modifying LDL cholesterol to prevent CV events, Tuesday, May 26, 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images

Stroes_CHOICE_II_25_may_2015_Final_uploaded.pdf (0,7MB)Stroes_CHOICE_II_25_may_2015_Final_uploaded.pdf (0,7MB)